Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $40.2M | $66.8M | $78.6M | $60.7M | $53.8M | $84.9M | $117M | $123M | $131M | $114M |
| Revenue growth | — | 66.1% | 17.6% | -22.8% | -11.3% | 57.7% | 37.6% | 5.5% | 6.0% | -12.9% |
| Gross profit | $20.4M | $34.7M | $39.4M | $29.2M | $24.1M | $41.2M | $53.4M | $57.0M | $55.4M | $48.9M |
| Gross margin | 50.7% | 51.9% | 50.2% | 48.2% | 44.8% | 48.6% | 45.7% | 46.2% | 42.4% | 43.0% |
| Operating income | $4.15M | $3.61M | $5.18M | $2.55M | -$1.22M | $8.46M | $10.7M | $10.4M | $3.39M | -$3.73M |
| Operating margin | 10.3% | 5.4% | 6.6% | 4.2% | -2.3% | 10.0% | 9.2% | 8.5% | 2.6% | -3.3% |
| Net income | $2.66M | $975K | $3.04M | $2.32M | -$895K | $7.28M | $8.46M | $9.34M | $2.89M | -$2.53M |
| Net margin | 6.6% | 1.5% | 3.9% | 3.8% | -1.7% | 8.6% | 7.2% | 7.6% | 2.2% | -2.2% |
| EPS (diluted) | $0.26 | $0.09 | $0.29 | $0.22 | -$0.09 | $0.68 | $0.78 | $0.79 | $0.24 | -$0.21 |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $4.29M | $7.24M | $11.0M | -$8.40M | $3.25M | $10.8M | -$1.39M | $16.2M | $3.82M | $7.32M |
| Capital expenditures | $339K | $745K | $2.21M | $620K | $658K | $994K | $1.36M | $1.29M | $1.32M | $1.63M |
| Free cash flow | $3.95M | $6.50M | $8.75M | -$9.03M | $2.59M | $9.85M | -$2.75M | $14.9M | $2.50M | $5.68M |
| Share buybacks | $978K | $62.0K | — | $1.14M | $74.0K | $0.00 | — | $0.00 | $1.04M | $0.00 |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $28.6M | $13.3M | $17.9M | $7.61M | $10.3M | $21.2M | $13.4M | $45.3M | $19.8M | $14.2M |
| Total assets | $42.8M | $62.5M | $67.2M | $59.7M | $62.0M | $104M | $110M | $135M | $152M | $151M |
| Total liabilities | $5.06M | $23.2M | $24.3M | $14.9M | $17.3M | $49.1M | $45.1M | $38.5M | $52.5M | $47.7M |
| Long-term debt | — | — | — | — | $0.00 | $16.0M | $12.0M | $7.94M | $7.54M | $1.41M |
| Shareholders' equity | $37.8M | $39.3M | $42.9M | $44.8M | $44.8M | $54.8M | $65.0M | $96.3M | $99.8M | $104M |
| Retained earnings | $11.7M | $12.6M | $15.7M | $18.0M | $17.1M | $24.4M | $32.9M | $42.2M | $45.1M | $42.6M |
| Shares (wtd avg diluted) | 10.3M | 10.3M | 10.4M | 10.4M | 10.3M | 10.7M | 10.9M | 11.8M | 12.2M | 12.2M |
Every figure is extracted from INTEST CORP’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.